Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
05/2003
05/15/2003US20030092675 Skin treatment using a new retinoid
05/15/2003US20030092674 Antiinflammatory agents; rheumatic diseases; autoimmune diseases; anticancer agents; antitumor agents
05/15/2003US20030092673 Chitosan mixcrocrystals
05/15/2003US20030092671 Synergistic mixture of low molecular weight heparin and dermatan sulfate; anticoagulants
05/15/2003US20030092670 PTPase inhibitors and method of using same
05/15/2003US20030092669 Method for normalizing insulin levels
05/15/2003US20030092668 Methods and compositions for reducing ischemic injury of the heart by administering adenosine receptor agonists and antagonists
05/15/2003US20030092666 Compositions and methods for nucleic acid delivery to the lung
05/15/2003US20030092663 Immunization-free methods for treating antigen-stimulated inflammation in a mammalian host and shifting the host's antigen immune responsiveness to a Th1 phenotype
05/15/2003US20030092655 Delivery system for nucleic acids
05/15/2003US20030092646 Method and reagent for the inhibition of CD20
05/15/2003US20030092645 Cloning, expression, viral and delivery vectors and hosts
05/15/2003US20030092644 1-( beta -L-ribofuranosyl)-1,2,4-triazole-3-carboxamide as animmunomodulator; viricides
05/15/2003US20030092642 Diphosphate salt of a 4" -substituted-9-deoxo-9A-AZA-9A-homoerythromycin derivative and its pharmaceutical composition
05/15/2003US20030092640 Water, azalide compound, 25-75% propylene glycol, and acids
05/15/2003US20030092638 Protopanaxadiol and protopanaxatriol and their use as anti-cancer agents
05/15/2003US20030092637 Novel compounds
05/15/2003US20030092636 Treatment and prevention of paresthesia comprising co-therapy with anticonvulsant derivatives and potassium
05/15/2003US20030092635 Galenical preparations of dapsone and related sulphones, and method of therapeutic and preventative treatment of disease
05/15/2003US20030092633 Preventing desensitization of receptors
05/15/2003US20030092630 Amino acid side chain-modified substrates of the enzyme; obtaining locally limited inhibition; treating inflammation, psoriasis, periodontitis, allergies, arthritis, tumors or autoimmune diseases
05/15/2003US20030092615 Nucleic acids, proteins, and antibodies
05/15/2003US20030092612 Use of antimicrobial peptides as preservatives in ophthalmic preparations, including solutions, emulsions, and suspensions
05/15/2003US20030092611 Nucleic acids, proteins, and antibodies
05/15/2003US20030092604 Novel inhibitors of vascular endothelial growth factor activity, their uses and processes for their production
05/15/2003US20030092602 Use of neurokinin receptor antagonists to treat androgen-dependent diseases
05/15/2003US20030092180 Inhibition of gene expression by delivery of small interfering RNA to post-embryonic animal cells in vivo
05/15/2003US20030092144 Production of farnesol and geranylgeraniol
05/15/2003US20030092059 Human antibodies that bind human TNFalpha
05/15/2003US20030092054 Protein complexes and assays for screening anti-cancer agents
05/15/2003US20030092046 Monomer for use in huaman therapeutics and diagnostics
05/15/2003US20030092042 Diagnosing cancer in mammals; obtain tissue sample, extract nucleotide sequences, detect galinin gene, determine copy number for gene, compare to control, amplified copy number indicates cancer
05/15/2003US20030092030 Wit 3.0, a novel gene to control soft tissue wound healing
05/15/2003US20030091974 Detecting compounds capable of exhausting mast cells; culture mast cells, incubate with modulator, measure mast cell death, classify compound
05/15/2003US20030091670 Natural compositions for the prevention of LDL oxidations
05/15/2003US20030091669 Mixture saponin, sugars and protein; solvent extraction, drying, sterilization; brain disorders, Alzheimer's disease
05/15/2003US20030091668 Process and composition for controlling fecal hair excretion and trichobezoar formation
05/15/2003US20030091667 Clear, colorless solution; mixture of surfactant and microbiocide
05/15/2003US20030091656 Analgesics for osteoporosis, rheumatic diseases; side effect reduction; extract from hops
05/15/2003US20030091654 Dietetics, antidiabetic agents; using chromium complex
05/15/2003US20030091651 Oil homogenized with sterols; protective coating for stomach
05/15/2003US20030091650 Ratite oil as a topical adjuvant and transdermal carrier
05/15/2003US20030091648 Hydrophilic core overcoated with hydrophobic hot melt lipid; for water soluble vitamins
05/15/2003US20030091645 Organic compounds
05/15/2003US20030091644 Low concentration of peroxide for treating or preventing vaginal infections
05/15/2003US20030091643 Amorphous mixture of acid sensitive drug and addition polymer; chemical resistance, stability
05/15/2003US20030091642 Composition in the form of a gel for receiving an active ingredient in a solution or suspension, especially for application on a mucous membrane and method of production thereof
05/15/2003US20030091639 Pharmaceutical compositions containing beta-lapachone, or derivatives or analogs thereof, and methods of using same
05/15/2003US20030091636 Antiinflammatory agents; uniform dissolving; oral bioavailability
05/15/2003US20030091635 Sustained release; reduced tendency to drug abruse
05/15/2003US20030091633 Pure form; cardiovascular disorders; side effect reduction
05/15/2003US20030091632 Controlled-release sedative-hypnotic compositions and methods related thereto
05/15/2003US20030091631 Method of providing sustained analgesia with buprenorphine
05/15/2003US20030091630 Formulation of an erodible, gastric retentive oral dosage form using in vitro disintegration test data
05/15/2003US20030091629 Absorption; pH adjustment; bioavailability
05/15/2003US20030091628 Anhydrous; granulation, compression; dryness; antidepressants
05/15/2003US20030091627 Rate-controlled delivery of macrolides
05/15/2003US20030091622 Process for producing composite preparation containing nucleic acid
05/15/2003US20030091621 Encapsulated drugs
05/15/2003US20030091620 Transdermal drug delivery systems containing quaternary ammonium salts and methods of using the same
05/15/2003US20030091616 Method for making infection-resistant fabricated textile articles for biomedical applications
05/15/2003US20030091615 In food, beverages; reduced dehydration
05/15/2003US20030091614 Compositions normalizing circadian rhythm
05/15/2003US20030091611 Antiproliferative agents ; antiinflammatory agents; insertable stent
05/15/2003US20030091610 Use of non-digestible polymeric foams to sequester ingested materials thereby inhibiting their absorption by the body
05/15/2003US20030091607 Wrinkle resistance; cosmetics
05/15/2003US20030091602 Crosslinked polymers; photopolymerization
05/15/2003US20030091601 In situ topical applying
05/15/2003US20030091596 Antiallergens; enzymeric dissolving of cell wall
05/15/2003US20030091594 CD4-independent HIV envelope proteins as vaccines and therapeutics
05/15/2003US20030091589 Veterinary medicine; feeding yeast cells
05/15/2003US20030091574 Combination treatment of pancreatic cancer
05/15/2003US20030091572 Methods and compositions for the treatment and diagnosis of pain disorders using 2047
05/15/2003US20030091571 Methods and compositions for the diagnosis and treatment of hematological disorders using 2777
05/15/2003US20030091569 Methods for the treatment of carcinoma
05/15/2003US20030091561 Anticancer agents
05/15/2003US20030091555 Sterilizing food poison bacteria using ethylenediamine, or salt thereof as chelate compound
05/15/2003US20030091553 Use of histamine to treat liver disease
05/15/2003US20030091540 Uniform spreading into body cavities
05/15/2003US20030091537 Anticancer agents; gene coding immunomoderator cytokine protein
05/15/2003US20030091530 Preventives and/or remedies for hyperphosphatemia
05/15/2003US20030091518 Mixture containing plant extracts and oils
05/15/2003US20030091515 Method of treating mucositis
05/15/2003US20030091513 For drugs, pigments
05/15/2003US20030091512 Water stabilized medicinal aerosol formulation
05/15/2003US20030091511 Vaporization, cooling; forming aerosols; anxiolytic agents
05/15/2003US20030091510 Administering fungicide to mucous membrane
05/15/2003US20030091505 Antiserotonine agents; central nervous system disorders
05/15/2003US20030090017 Manikin and eye device apparatus, methods and articles of manufacture
05/15/2003US20030089369 Pressurised metered dose inhalers (MDI)
05/15/2003CA2789407A1 Inhibitor oligonucleotides and their use for specific repression of a gene
05/15/2003CA2669810A1 2-amino-thiazoline derivatives and their use as inhibitors of inducible no-synthase
05/15/2003CA2508907A1 Intraluminal device with a coating containing a therapeutic agent
05/15/2003CA2505129A1 Pharmaceutical compositions of marine sponge microciona prolifera
05/15/2003CA2472097A1 Antisense modulation of purinoreceptor p2x3
05/15/2003CA2470271A1 Deuterated pyrazolopyrimidinones and drugs containing said compounds
05/15/2003CA2469818A1 Anticancer compositions
05/15/2003CA2469406A1 Anticancer compositions
05/15/2003CA2468399A1 Combretastatin a-4 derivatives having antineoplastic activity
05/15/2003CA2467955A1 Lipoprotein lipase and lipoprotein lipase activators in the treatment of inflammatory conditions
1 ... 5468 5469 5470 5471 5472 5473 5474 5475 5476 5477 5478 5479 5480 5481 5482 5483 5484 5485 5486 5487 5488 ... 7860